CXCL9 and COVID-19: Patients with fatal COVID-19 also showed significantly higher plasma levels of the neutrophil recruiting CXCL-8 [49] as well as of the T and NK cell-attracting CXCL-9 [50], as compared to severe and/or mild COVID-19 patients [22,46].